Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second tri-specific antibody, IM1305, named as development ...
Data from the National Financial Regulatory Administration show that by the end of 2025, the balance of funds in use in China's insurance industry had reached 38.48 trillion yuan ($5.57 trillion), up ...
Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...
Commercial plant biotechnology research has all but died in Denmark. Of the three major companies involved in the field—Carlsberg (Copenhagen), Danisco (Copenhagen), and DLF-Trifolium (St.
Genexis engineers microbes and uses precision fermentation to produce AOF growth factors, serum proteins and special-purpose laboratory culture media ...
Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.
Elon explicitly pushed back on today’s Business Insider “Macrohard stalled → pivot to Tesla” FUD. XAI minor staff churn, ...
Thinking about Botox injections? You've got a new option -- Planned Parenthood. The organization is actively seeking new revenue streams after federal budget cuts have left it with a $100 million gap.
In addition to terminating the department of Agricultural Sciences Education and Communication, the college will see a transformed agronomy department.
Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.
Cognitive scientist Henkjan Honing has published a peer-reviewed essay in Current Biology that pulls together two decades of evidence from genetics, neuroscience, and infant research to argue that ...
As the contours of state budget negotiations begin to come into focus, health care interests, both institutional and labor, ...